Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot pharmacogenetic study of clozapine efficacy and tolerability in psychotic disorders
2007-003867-36Phase 4Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Oct 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clozapine in schizophrenia, schizoaffective disorder and Bipolar disorder with psychotic features, sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Clinical efficacy and tolerability of clozapine. Started Oct 2007; status: completed.
02
Drugs
clozapine
03
Conditions
schizophreniaschizoaffective disorderBipolar disorder with psychotic features
Beyond the preview
Go deeper on 2007-003867-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003867-36.